Docet Podcast show

Docet Podcast

Summary: The Optometric Quarterly audio files are now available as podcasts. Subscribing to this podcast is completely free, and you can cancel it at any time. If you subscribe to this podcast you will automatically receive each new issue of this programme every quarter. Podcasting lets you automatically receive the latest issue of Optometric Quarterly as soon as it's available.

Join Now to Subscribe to this Podcast

Podcasts:

 OQ88 02: Fundus autofluorescence | File Type: audio/mpeg | Duration: 16:21

This edition includes items on retinal densitometry, fundus autofluorescence, measuring visual acuity and the regular Quarterly Review of journals.

 OQ88 03: Measuring visual acuity | File Type: audio/mpeg | Duration: 16:25

This edition includes items on retinal densitometry, fundus autofluorescence, measuring visual acuity and the regular Quarterly Review of journals.

 OQ88 04: Quarterly Review | File Type: audio/mpeg | Duration: 14:00

This edition includes items on retinal densitometry, fundus autofluorescence, measuring visual acuity and the regular Quarterly Review of journals.

 OQ88 01:Retinal densitometry | File Type: audio/mpeg | Duration: 17:17

This edition includes items on retinal densitometry, fundus autofluorescence, measuring visual acuity and the regular Quarterly Review of journals.

 OQ88 02: Fundus autofluorescence | File Type: audio/mpeg | Duration: 16:21

This edition includes items on retinal densitometry, fundus autofluorescence, measuring visual acuity and the regular Quarterly Review of journals.

 OQ88 03: Measuring visual acuity | File Type: audio/mpeg | Duration: 16:25

This edition includes items on retinal densitometry, fundus autofluorescence, measuring visual acuity and the regular Quarterly Review of journals.

 OQ88 04: Quarterly Review | File Type: audio/mpeg | Duration: 14:00

This edition includes items on retinal densitometry, fundus autofluorescence, measuring visual acuity and the regular Quarterly Review of journals.

 OQ87 1 Epiretinal membrane | File Type: audio/mpeg | Duration: 12:15

This edition of OQ includes items on the epiretinal membrane, the ocular side effects of Tamoxifen, the Age Related Eye Disease Study 2 (AREDS2) and the regular Quarterly Review of journals.

 OQ87 2 The ocular side effects of Tamoxifen | File Type: audio/mpeg | Duration: 15:23

This edition of OQ includes items on the epiretinal membrane, the ocular side effects of Tamoxifen, the Age Related Eye Disease Study 2 (AREDS2) and the regular Quarterly Review of journals.

 OQ87 3 Age-Related Eye Disease Study 2 (AREDS2) | File Type: audio/mpeg | Duration: 15:33

This edition of OQ includes items on the epiretinal membrane, the ocular side effects of Tamoxifen, the Age Related Eye Disease Study 2 (AREDS2) and the regular Quarterly Review of journals.

 OQ87 4 Quarterly Review | File Type: audio/mpeg | Duration: 15:12

This edition of OQ includes items on the epiretinal membrane, the ocular side effects of Tamoxifen, the Age Related Eye Disease Study 2 (AREDS2) and the regular Quarterly Review of journals.

 OQ87 1 Epiretinal membrane | File Type: audio/mpeg | Duration: 12:15

This edition of OQ includes items on the epiretinal membrane, the ocular side effects of Tamoxifen, the Age Related Eye Disease Study 2 (AREDS2) and the regular Quarterly Review of journals.

 OQ87 2 The ocular side effects of Tamoxifen | File Type: audio/mpeg | Duration: 15:23

This edition of OQ includes items on the epiretinal membrane, the ocular side effects of Tamoxifen, the Age Related Eye Disease Study 2 (AREDS2) and the regular Quarterly Review of journals.

 OQ87 3 Age-Related Eye Disease Study 2 (AREDS2) | File Type: audio/mpeg | Duration: 15:33

This edition of OQ includes items on the epiretinal membrane, the ocular side effects of Tamoxifen, the Age Related Eye Disease Study 2 (AREDS2) and the regular Quarterly Review of journals.

 OQ87 4 Quarterly Review | File Type: audio/mpeg | Duration: 15:12

This edition of OQ includes items on the epiretinal membrane, the ocular side effects of Tamoxifen, the Age Related Eye Disease Study 2 (AREDS2) and the regular Quarterly Review of journals.

Comments

Login or signup comment.